ATE93629T1 - Verfahren zur diagnose in vitro von menschlichen cytomegalovirusinfektionen und anwendung von monoklonalen antikoerpern gegen cytomegaloviren, die mit einer cytomegalovirusinduzierten proteinkinase reagieren. - Google Patents

Verfahren zur diagnose in vitro von menschlichen cytomegalovirusinfektionen und anwendung von monoklonalen antikoerpern gegen cytomegaloviren, die mit einer cytomegalovirusinduzierten proteinkinase reagieren.

Info

Publication number
ATE93629T1
ATE93629T1 AT85400845T AT85400845T ATE93629T1 AT E93629 T1 ATE93629 T1 AT E93629T1 AT 85400845 T AT85400845 T AT 85400845T AT 85400845 T AT85400845 T AT 85400845T AT E93629 T1 ATE93629 T1 AT E93629T1
Authority
AT
Austria
Prior art keywords
cytomegalovirus
protein kinase
vitro
diagnosis
reactive
Prior art date
Application number
AT85400845T
Other languages
English (en)
Inventor
Florian Horaud
Susan Michelson
Octavian Barzu
Andre Boue
Claire Amadei
Original Assignee
Pasteur Institut
Centre Nat Rech Scient
Inst Nat Sante Rech Med
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9303607&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE93629(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pasteur Institut, Centre Nat Rech Scient, Inst Nat Sante Rech Med filed Critical Pasteur Institut
Application granted granted Critical
Publication of ATE93629T1 publication Critical patent/ATE93629T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/081—DNA viruses
    • C07K16/085—Orthoherpesviridae (F), e.g. pseudorabies virus or Epstein-Barr virus
    • C07K16/089—Cytomegalovirus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physics & Mathematics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pathology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT85400845T 1984-04-27 1985-04-29 Verfahren zur diagnose in vitro von menschlichen cytomegalovirusinfektionen und anwendung von monoklonalen antikoerpern gegen cytomegaloviren, die mit einer cytomegalovirusinduzierten proteinkinase reagieren. ATE93629T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8406769A FR2563630B1 (fr) 1984-04-27 1984-04-27 Anticorps monoclonaux anticytomegalovirus et procedes pour le diagnostic in vitro des infections par les cytomegalovirus humains et d'une proteine-kinase inductible par les cytomegalovirus et susceptible d'etre reconnue par les susdits anticorps monoclonaux
EP85400845A EP0165830B1 (de) 1984-04-27 1985-04-29 Verfahren zur Diagnose in vitro von menschlichen Cytomegalovirusinfektionen und Anwendung von monoklonalen Antikörpern gegen Cytomegaloviren, die mit einer cytomegalovirusinduzierten Proteinkinase reagieren

Publications (1)

Publication Number Publication Date
ATE93629T1 true ATE93629T1 (de) 1993-09-15

Family

ID=9303607

Family Applications (1)

Application Number Title Priority Date Filing Date
AT85400845T ATE93629T1 (de) 1984-04-27 1985-04-29 Verfahren zur diagnose in vitro von menschlichen cytomegalovirusinfektionen und anwendung von monoklonalen antikoerpern gegen cytomegaloviren, die mit einer cytomegalovirusinduzierten proteinkinase reagieren.

Country Status (7)

Country Link
US (4) US6248513B1 (de)
EP (1) EP0165830B1 (de)
JP (2) JP2571358B2 (de)
AT (1) ATE93629T1 (de)
CA (1) CA1269930A (de)
DE (1) DE3587542T2 (de)
FR (1) FR2563630B1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2563630B1 (fr) * 1984-04-27 1988-02-19 Pasteur Institut Anticorps monoclonaux anticytomegalovirus et procedes pour le diagnostic in vitro des infections par les cytomegalovirus humains et d'une proteine-kinase inductible par les cytomegalovirus et susceptible d'etre reconnue par les susdits anticorps monoclonaux
GB8605646D0 (en) * 1986-03-07 1986-04-16 Medical Res Council Vaccines
DE3619902A1 (de) * 1986-06-13 1988-03-03 Biotechnolog Forschung Gmbh Cmv-dna-strukturen, expressionsvektor dafuer, cmv-proteinstrukturen und deren verwendung
RU2134422C1 (ru) * 1996-08-29 1999-08-10 Научно-исследовательский институт детских инфекций Способ иммуноферментного выявления фаз оппортунистических инфекций
RU2123188C1 (ru) * 1997-07-08 1998-12-10 Московский областной научно-исследовательский клинический институт Способ прогнозирования развития цитомегаловирусной инфекции у реципиентов почечных аллотрансплантатов
RU2176794C2 (ru) * 2000-03-07 2001-12-10 Пермская государственная медицинская академия Способ иммунодиагностики инфекций
US7078061B2 (en) * 2002-12-26 2006-07-18 Meso Scale Technologies Llc Methods, compositions and kits for biomarker extraction
GB0700133D0 (en) 2007-01-04 2007-02-14 Humabs Llc Human cytomegalovirus neutralising antibodies and use thereof
US7947274B2 (en) 2007-01-04 2011-05-24 Humabs, LLC. Human cytomegalovirus neutralising antibodies and use thereof
US8124093B2 (en) 2008-07-16 2012-02-28 Institute For Research In Biomedicine Human cytomegalovirus neutralizing antibodies and use thereof
NZ600974A (en) 2009-12-23 2014-08-29 4Antibody Ag Binding members for human cytomegalovirus

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4294817A (en) * 1977-11-25 1981-10-13 International Diagnostic Technology, Inc. Method of fluoro immunoassay
US4879219A (en) * 1980-09-19 1989-11-07 General Hospital Corporation Immunoassay utilizing monoclonal high affinity IgM antibodies
US4782015A (en) * 1984-03-30 1988-11-01 Syntex (U.S.A.) Inc. Method for determining the presence of malignant cells
FR2563630B1 (fr) * 1984-04-27 1988-02-19 Pasteur Institut Anticorps monoclonaux anticytomegalovirus et procedes pour le diagnostic in vitro des infections par les cytomegalovirus humains et d'une proteine-kinase inductible par les cytomegalovirus et susceptible d'etre reconnue par les susdits anticorps monoclonaux

Also Published As

Publication number Publication date
JP2571358B2 (ja) 1997-01-16
CA1269930A (en) 1990-06-05
US6248513B1 (en) 2001-06-19
FR2563630B1 (fr) 1988-02-19
JPS6122100A (ja) 1986-01-30
JPH0920796A (ja) 1997-01-21
FR2563630A1 (fr) 1985-10-31
EP0165830B1 (de) 1993-08-25
US20010039008A1 (en) 2001-11-08
DE3587542T2 (de) 1993-12-23
JP2742406B2 (ja) 1998-04-22
US20020187466A1 (en) 2002-12-12
US6949628B2 (en) 2005-09-27
US6183754B1 (en) 2001-02-06
EP0165830A1 (de) 1985-12-27
DE3587542D1 (de) 1993-09-30

Similar Documents

Publication Publication Date Title
DE68927459D1 (de) Nachweis einer neurologischen Krankheit oder einer Funktionsstörung
DE3587724D1 (de) Antikörper verwendende diagnostische Methoden.
FI895959A7 (fi) Koostumus, diagnostinen käyttöpakkaus ja menetelmä vasta-aineiden nope aksi toteamiseksi
EP0261224A4 (de) Synthetische htlv-iii-peptid-zusammensetzungen und ihre verwendung.
ATE93629T1 (de) Verfahren zur diagnose in vitro von menschlichen cytomegalovirusinfektionen und anwendung von monoklonalen antikoerpern gegen cytomegaloviren, die mit einer cytomegalovirusinduzierten proteinkinase reagieren.
KR890002547A (ko) Hiv 감염의 치료 및 진단용 모노클로날항체 및 펩티드
ES2032447T3 (es) Nuevos anticuerpos monoclonales y su produccion y uso.
GB2188941B (en) Monoclonal antibodies recognizing human interleukin-2-receptor
IL132414A0 (en) Type alpha platelet derived growth factor receptor gene
DE3776525D1 (de) Immunochemisches verfahren zur bestimmung von stabilem glykosiliertem haemoglobin.
FI922666A0 (fi) Diagnostiskt foerfarande.
FI902735A7 (fi) Monoklonaalinen vasta-aine, joka reagoi tiettyyn laajasti erilaisissa ihmisleukemia- ja lymfomasoluissa esiintyvään antigeeniin ja menetelmä sen käyttämiseksi diagnoosiin ja hoitoon
DE69026875D1 (de) Immunobestimmung von menschlichem osteocalcin, reagenz und satz dafür
ATE68601T1 (de) Reagenz zur bestimmung durch haemagglutination von antikoerpern gegen bakterien-toxine, verfahren zu ihrer herstellung und verwendung.
ATA319087A (de) Immunologisch aktive polypeptide, die für die herstellung von antimalaria-vakzinen und die diagnostischen ausrüstungen für die auffindung von antisporozoit-antikörpern nützlich sind
DE3789597D1 (de) Nachweis eines mit atmungskrankheiten verbundenen einzelstammes von chlamydia.
ATE147759T1 (de) Verfahren und materialien zum nachweis und therapie von hiv
DE3580524D1 (de) Monoklonaler antikoerper geeignet zur spezifischen unterscheidung von humanen hepatokarzinomzellen.
BG92796A (bg) Метод за откриване на антитела в кръвта,мембранна лента и мембранна батерия за провеждана на метода
IE882250L (en) Monoclonal antibodies and methods for diagnosis of Phytophthora infection
EP0453419A3 (en) Use of the sp-2 monoclonal antibody for diagnostics and for monitoring of the hiv infection progress
ATE146597T1 (de) Verfahren zur diagnose von hiv-infektionen
Chernavskaya et al. Enhancing the sensitivity of parapertussis diagnosticum.
NO177310C (no) Antigent polypeptid fra HBxAg, antistoff som reagerer med polypeptidet, diagnostisk analysesystem for bestemmelse av tilstedeværelsen av HBxAg i en kroppspröve, samt anvendelse av polypeptidet til in vitro diagnose

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EELA Cancelled due to lapse of time